Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesAdvances in the treatment of newly diagnosed glioblastomaOverview of current immunotherapeutic strategies for gliomaFunctional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesThe Promise of Preventive Cancer VaccinesCheckpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous SystemImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Engineering New Approaches to Cancer VaccinesWhat next for newly diagnosed glioblastoma?Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trialHistory and current state of immunotherapy in glioma and brain metastasis.Single vs. combination immunotherapeutic strategies for glioma.The Viral Connection to Glioblastoma.Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.Neurosurgery concepts: Key perspectives on deferoxamine and chronic hydrocephalus from intraventricular hemorrhage, laboratory dissection training in neurosurgical residency, tetanus toxoid and dendritic cell vaccines for glioblastoma, and intracranMaking many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines.Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines.The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.Emerging immunotherapies for glioblastomaImmunotherapy in glioblastoma: emerging options in precision medicinePrioritization schema for immunotherapy clinical trials in glioblastoma.Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls.A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatmentRecent advances and future of immunotherapy for glioblastoma.Promise of cancer stem cell vaccine.Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles.Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes.Advances in Immunotherapy for Glioblastoma Multiforme.Immunogenicity is preferentially induced in sparse dendritic cell cultures.Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine.Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.Vaccination strategies for neuro-oncology.Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes.Vaccines for established cancer: overcoming the challenges posed by immune evasion.Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization.
P2860
Q26752558-EE27D677-E31E-4F89-BC58-0529A268A5E4Q26773514-1057F346-92FA-4065-B23E-EBFC38502CDCQ26776345-81FF6733-E7E6-4D71-9459-1CC08D5A4458Q26777948-815B4CD3-1B86-45C8-AB98-F55BE454C57FQ26783742-5BB9206E-0582-45C9-BC98-6C5145B22BD1Q28066906-A09BBB46-6529-48F6-8E40-55295490BBC9Q28078539-53614397-0BDC-48AB-A19F-A85B84BD66CBQ28085563-D4942453-96B2-46B2-A0EE-8F51F3FC67F2Q28086839-2CF91156-C4F1-418A-9E71-645173EFD7DCQ33429827-0034A5AA-5777-4CC8-B8B5-C343C44C1946Q33656811-B3BFDA6F-3CBD-42F5-81C3-3C4D3B1887E2Q33746041-8EB8107E-E412-40FD-BF22-1A190ECCC048Q34552036-8ABAD1E6-EBD3-4E51-BDA9-AEE9BE4A83E1Q34552791-4ED019DA-69D3-4864-85DF-5D912B4A0E89Q35925834-28CCCDDA-C4C8-4264-B860-C0F245FA69E5Q36007783-318183D9-58A4-4F85-B352-A9AA63B0968DQ36068746-B9A0C0E3-374D-45AB-A0E0-49CAA6B31CB2Q36255729-E5C1008B-5BDF-471C-972B-1B2852DDB711Q36388915-7E6FD689-DD6D-49A6-9D5A-462C9622D361Q36493820-85720172-6759-4692-BC15-08E1AECBCA45Q37025105-85F12D19-60CC-4CEF-95A3-BDFD09CD2AE7Q37050960-64DCE933-61BA-4E7A-B8FA-8A86F7A8F829Q37078999-DF4A94BB-6E25-478E-A60F-DEE5630D0074Q37086138-F8EEACB8-BE0B-4013-9AA6-3E5667977D56Q37125964-D6E30C25-9DAF-4706-B36F-6892771FDB78Q37203399-67DE8FD8-8C94-45C4-8757-FED1A507A940Q37239071-AFF9AF1F-B8DA-4545-914E-6EF42033EF2CQ37320126-70C50721-0F4C-4609-A4E4-D3D66F36FD62Q37616489-2088418C-7830-4E5D-AD29-DB02970303DCQ37671730-965224B2-6D9E-4B99-AB9F-0866E9165F49Q37680966-79668FE7-01B7-46B5-B43B-24545AFB7334Q37690509-D4055120-E1B9-46E3-B64C-75FA7EA04E16Q37736868-A1E9C9A7-452C-406B-A0C6-C39BB979E2A8Q38599166-392D476F-3D5C-444E-B134-01C5909FE1C3Q38603909-3C45120F-B800-4AF1-9A7C-E5E1995E7F1EQ38620079-174C8573-4ADC-48A1-86C5-A320A76BDC5CQ38665860-8FCCE767-20E2-4246-B52C-3A6BAF51C184Q38769021-73308E17-E0BC-48B4-8F10-9ABCF5A41391Q38773347-7D5B6697-2431-4067-BA48-A67F1985692EQ38776409-4E957FA1-85D3-429A-81A7-395BD65F8DAC
P2860
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@ast
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@en
type
label
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@ast
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@en
prefLabel
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@ast
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@en
P2093
P2860
P50
P356
P1433
P1476
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
@en
P2093
Duane A Mitchell
Elizabeth A Reap
Gary E Archer
James E Herndon
James J Vredenburgh
John H Sampson
Kendra L Congdon
Kristen A Batich
Luis Sanchez-Perez
Michael D Gunn
P2860
P2888
P304
P356
10.1038/NATURE14320
P407
P50
P577
2015-03-11T00:00:00Z